Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Regulatory News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

Share Price is delayed by 15 minutes
Get Live Data
2.75    -0.20 (-6.78%)
Bid:
2.50
Ask:
3.00
Spread: 0.50 (20.00%)
Market Cap: £11.69m
CIZ Live PriceLast checked at - London Stock Exchange

Intraday Cizzle Biotech Share Chart

Date   Source Headline
21st May 20267:51 amRNSNotice of AGM
7th May 20267:00 amRNSIssue of Options, Salary Waivers, Incentive Plan
6th May 20267:00 amRNSConversion of Convertible Loan Notes
30th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
2nd Apr 20267:00 amRNS£250,000 Funding Facility
23rd Feb 20267:00 amRNSProgress on Launch of Biomarker Test in USA
4th Feb 20267:00 amRNSPatent Granted in Canada
5th Nov 20257:01 amRNS£250,000 Convertible Loan Note Issue
5th Nov 20257:00 amRNSLOI with leading UK Clinical Diagnostic Group
27th Oct 202511:32 amRNSChange of Registered Office
30th Sep 20257:00 amRNSInterim Results
29th Sep 20257:00 amRNSUpdate on Clinical Laboratory Partnerships in USA
18th Aug 20257:00 amRNSCommercial Progress in USA
30th Jun 20251:45 pmRNSResult of AGM
6th Jun 202511:00 amRNSNotice of AGM
28th May 20257:00 amRNSHolding(s) in Company
20th May 20257:00 amRNS£150,000 Convertible Loan Note Issue
30th Apr 202511:18 amRNSFinal results for the year ended 31 December 2024
28th Apr 20257:00 amRNSContract in Caribbean and Update on CIZ1B
14th Apr 202510:00 amRNS-RLaunch of New Website
25th Mar 20257:00 amRNSAppointment of Non-Executive Director
24th Mar 20257:00 amRNSUpdate on Launch of CIZ1B Biomarker Assay
2nd Jan 20257:00 amRNSAppointment of Professor Dawn Coverley as CSO
16th Dec 20247:00 amRNSUpdate on Strategic Partnership in North America
21st Oct 20247:00 amRNSExecution of Agreement for North America
3rd Oct 20241:12 pmRNSUpdate on Licensing and Partnership Agreement
30th Sep 20247:00 amRNSInterim Results
16th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20247:00 amRNSCollaboration with Moffitt Cancer Center
25th Jul 20247:00 amRNSUpdate on Strategic Partnership in North America
18th Jul 20247:00 amRNSManufacturing Agreement with BBI Solutions
9th Jul 20247:00 amRNSIssue of Share Options in Lieu of Consultancy Fees
24th Jun 202412:42 pmRNSResult of AGM
17th Jun 20247:00 amRNSUpdate on North American Strategic Licensing MoU
3rd Jun 20247:00 amRNSNotice of Annual General Meeting
13th May 20247:00 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20249:12 amRNSFinal results for the year ended 31 December 2023
23rd Apr 202411:20 amRNSHolding(s) in Company
2nd Apr 20247:00 amRNSLicensing and Partnership MoU for North America
26th Mar 20247:00 amRNSPlacing to raise £0.62 million
28th Sep 20237:00 amRNSInterim Results
21st Sep 20237:00 amRNSUpdate on Put Option with Conduit
19th Sep 20237:00 amRNSCompletion of Evaluation Programme with Bio-Techne
8th Sep 20237:03 amRNSExtension of and update on Put Option with Conduit
15th Aug 20237:00 amRNSUpdate on Put Option with Conduit
10th Aug 20237:00 amRNSExpansion of Research Agreement and CIZ1B Update
30th Jun 20235:00 pmRNSTotal Voting Rights
28th Jun 202312:01 pmRNSResult of AGM
12th Jun 20232:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.